Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02646410 |
Date of registration:
|
29/12/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Optimization of Seasonal Malaria Chemoprevention (SMC) Delivery
SMC |
Scientific title:
|
Optimal Delivery of Seasonal Malaria Chemoprevention and Its Effects on the Acquisition of Malaria Immunity |
Date of first enrolment:
|
August 2014 |
Target sample size:
|
10000 |
Recruitment status: |
Unknown status |
URL:
|
https://clinicaltrials.gov/show/NCT02646410 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Factorial Assignment. Primary purpose: Prevention. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Mali
| | | | | | | |
Contacts
|
Name:
|
Alassane Dicko, MD |
Address:
|
|
Telephone:
|
|
Email:
|
adicko@icermali.org |
Affiliation:
|
|
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Age >= 3 months & < 60 months
Exclusion Criteria:
- severe, chronic illness
- known allergy to one of the study drugs (SP or AQ)
- known HIV positive subjects using Cotrimoxazole.
Age minimum:
3 Months
Age maximum:
59 Months
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Malaria
|
Anemia
|
Intervention(s)
|
Other: DDD+DOT
|
Other: FPD+DOT
|
Other: FPD+NDOT
|
Other: DDD+NDOT
|
Primary Outcome(s)
|
Hospital admission
[Time Frame: 1, 2, 3, 4 years of the intervention]
|
Coverage of SMC
[Time Frame: 1-5 weeks after last round of SMC in Year1]
|
Incidence of clinical malaria in Year 2
[Time Frame: up to 4 weeks after the last round of SMC]
|
Mortality rate
[Time Frame: 1, 2, 3, 4 years of the intervention]
|
Secondary Outcome(s)
|
moderate anemia
[Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
|
Clinical malaria in Year 1
[Time Frame: up to 4 weeks after the last round of SMC]
|
nutritional status
[Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
|
immune response to malaria parasite
[Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
|
molecular markers of resistance to SP + AQ
[Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
|
malaria parasitemia
[Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|